Loading...

Nitti, Victor William

Title(s)Professor, Urology
Phone3107940206
vCardDownload vCard
    Other Positions
    Title(s)Professor, Obstetrics and Gynecology


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Rovner E, Chai TC, Jacobs S, Christ G, Andersson KE, Efros M, Nitti V, Davies K, McCullough AR, Melman A. Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn. 2020 Feb; 39(2):744-753. PMID: 31945197.
      View in: PubMed
    2. Hoffman D, Sussman RD, Pape DM, Smilen SW, Rosenblum N, Nitti VW, Brucker BM. Radiation exposure during videourodynamic testing: Is dose reduction possible using a standardized protocol? Neurourol Urodyn. 2020 Feb; 39(2):715-720. PMID: 31846117.
      View in: PubMed
    3. Drain A, Enemchukwu E, Shah N, Syan R, Rosenblum N, Nitti VW, Brucker BM. Current Role of Urethrolysis and Partial Excision in Patients Seeking Revision of Anti-Incontinence Sling. Female Pelvic Med Reconstr Surg. 2019 Nov/Dec; 25(6):409-414. PMID: 29787462.
      View in: PubMed
    4. Vurture G, Peyronnet B, Palma JA, Sussman RD, Malacarne DR, Feigin A, Palmerola R, Rosenblum N, Frucht S, Kaufmann H, Nitti VW, Brucker BM. Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease. Int Neurourol J. 2019 Sep; 23(3):211-218. PMID: 31607100.
      View in: PubMed
    5. Glass D, Lin FC, Khan AA, Van Kuiken M, Drain A, Siev M, Peyronett B, Rosenblum N, Brucker BM, Nitti VW. Impact of preoperative urodynamics on women undergoing pelvic organ prolapse surgery. Int Urogynecol J. 2019 Aug 27. PMID: 31456030.
      View in: PubMed
    6. Peng M, Sussman RD, Escobar C, Palmerola R, Pape DM, Smilen SS, Rosenblum N, Brucker BM, Peyronnet B, Nitti VW. Rectus Fascia Versus Fascia Lata for Autologous Fascial Pubovaginal Sling: A Single-Center Comparison of Perioperative and Functional Outcomes. Female Pelvic Med Reconstr Surg. 2019 Jul 22. PMID: 31343622.
      View in: PubMed
    7. Sandhu JS, Breyer B, Comiter C, Eastham JA, Gomez C, Kirages DJ, Kittle C, Lucioni A, Nitti VW, Stoffel JT, Westney OL, Murad MH, McCammon K. Incontinence after Prostate Treatment: AUA/SUFU Guideline. J Urol. 2019 08; 202(2):369-378. PMID: 31059663.
      View in: PubMed
    8. Palmerola R, Peyronnet B, Rebolos M, Khan A, Sussman RD, Escobar C, Smith S, Rosenblum N, Nitti VW. Trends in Stress Urinary Incontinence Surgery at a Tertiary Center: Midurethral Sling Use Following the AUGS/SUFU Position Statement. Urology. 2019 09; 131:71-76. PMID: 31229514.
      View in: PubMed
    9. Kobashi K, Nitti V, Margolis E, Sand P, Siegel S, Khandwala S, Newman D, MacDiarmid SA, Kan F, Michaud E. A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome. Urology. 2019 Sep; 131:77-82. PMID: 31199966.
      View in: PubMed
    10. Drangsholt S, Peyronnet B, Arcila-Ruiz M, Sussman RD, Palmerola R, Pape DR, Rosenblum N, Nitti VW, Brucker BM. Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre. Arab J Urol. 2019 Mar; 17(1):82-86. PMID: 31258948.
      View in: PubMed
    11. Syan R, Peyronnet B, Drain A, Enemchukwu E, Malacarne DR, Rosenblum N, Nitti VW, Brucker BM. Exploring stress urinary incontinence outcomes after sling excision for perforation or exposure. Low Urin Tract Symptoms. 2019 Sep; 11(4):206-210. PMID: 30900401.
      View in: PubMed
    12. Uren AD, Cotterill N, Harding C, Hillary C, Chapple C, Lasch K, Stroupe A, Deshpande C, Delbecque L, Van Koeveringe G, Oelke M, Belal M, Bosch R, Blok B, Nitti V, Gotoh M, Takei M, Crawford B, Klaver M, Bongaerts D, Hakimi Z, Kos T, Abrams P. The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder. Neurourol Urodyn. 2019 03; 38(3):996-1004. PMID: 30801826.
      View in: PubMed
    13. Sussman RD, Kozirovsky M, Telegrafi S, Peyronnet B, Palmerola R, Smilen S, Pape DM, Rosenblum N, Nitti VW, Brucker BM. Gel-Infused Translabial Ultrasound in the Evaluation of Female Urethral Stricture. Female Pelvic Med Reconstr Surg. 2019 Jan 17. PMID: 30664026.
      View in: PubMed
    14. Hoffman D, Vijay V, Peng M, Sussman RD, Rosenblum N, Brucker BM, Peyronnet B, Nitti VW. Effect of Radiation on Male Stress Urinary Incontinence and the Role of Urodynamic Assessment. Urology. 2019 Mar; 125:58-63. PMID: 30508511.
      View in: PubMed
    15. Peyronnet B, O'Connor E, Khavari R, Capon G, Manunta A, Allue M, Hascoet J, Nitti VW, Gamé X, Gilleran J, Castro-Sader L, Cornu JN, Waltregny D, Ahyai S, Chung E, Elliott DS, Fournier G, Brucker BM. AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review. Neurourol Urodyn. 2019 08; 38 Suppl 4:S28-S41. PMID: 30298943.
      View in: PubMed
    16. Drangsholt S, Ruiz MJA, Peyronnet B, Rosenblum N, Nitti V, Brucker B. Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them? World J Urol. 2019 Jul; 37(7):1389-1394. PMID: 30288596.
      View in: PubMed
    17. Chapple CR, Osman NI, Birder L, Dmochowski R, Drake MJ, van Koeveringe G, Nitti VW, Oelke M, Smith PP, Yamaguchi O, Wein A, Abrams P. Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB). Neurourol Urodyn. 2018 11; 37(8):2928-2931. PMID: 30203560.
      View in: PubMed
    18. Peyronnet B, Vurture G, Palma JA, Malacarne DR, Feigin A, Sussman RD, Biagioni MC, Palmerola R, Gilbert R, Rosenblum N, Frucht S, Kaufmann H, Nitti VW, Brucker BM. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort. Parkinsonism Relat Disord. 2018 12; 57:22-26. PMID: 30037689.
      View in: PubMed
    19. Vurture G, Peyronnet B, Feigin A, Biagioni MC, Gilbert R, Rosenblum N, Frucht S, Di Rocco A, Nitti VW, Brucker BM. Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease. Neurourol Urodyn. 2018 11; 37(8):2669-2677. PMID: 29767449.
      View in: PubMed
    20. Weissbart SJ, Zimmern PE, Nitti VW, Lemack GE, Kobashi KC, Vasavada SP, Wein AJ. The history of the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction. Neurourol Urodyn. 2018 08; 37(6):2015-2025. PMID: 29575219.
      View in: PubMed
    21. Peyronnet B, Nitti VW, Brucker BM. Long-term efficacy: The Achille's heel of the male sling? Prog Urol. 2018 03; 28(4):191-192. PMID: 29402704.
      View in: PubMed
    22. Peyronnet B, Gamé X, Vurture G, Nitti VW, Brucker BM. Botulinum Toxin Use in Neurourology. Rev Urol. 2018; 20(2):84-93. PMID: 30288145.
      View in: PubMed
    23. Kretschmer A, Nitti V. Surgical Treatment of Male Postprostatectomy Incontinence: Current Concepts. Eur Urol Focus. 2017 10; 3(4-5):364-376. PMID: 29174616.
      View in: PubMed
    24. Drake MJ, Nitti VW, Ginsberg DA, Brucker BM, Hepp Z, McCool R, Glanville JM, Fleetwood K, James D, Chapple CR. Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis. BJU Int. 2017 11; 120(5):611-622. PMID: 28670786.
      View in: PubMed
    25. Ginsberg DA, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW. Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder. J Urol. 2017 10; 198(4):897-904. PMID: 28536084.
      View in: PubMed
    26. Tubaro A, Batista JE, Nitti VW, Herschorn S, Chapple CR, Blauwet MB, Siddiqui E, Huang M, Oelke M. Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies. Ther Adv Urol. 2017 Dec; 9(6):137-154. PMID: 28588652.
      View in: PubMed
    27. Nitti VW. Midurethral sling erosion: NYU Case of the Month, August 2017. Rev Urol. 2017; 19(3):185-186. PMID: 29302242.
      View in: PubMed
    28. Vigil HR, Mallick R, Nitti VW, Lavallée LT, Breau RH, Hickling DR. Risk Factors for Urinary Tract Infection following Mid Urethral Sling Surgery. J Urol. 2017 05; 197(5):1268-1273. PMID: 28034608.
      View in: PubMed
    29. Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. J Urol. 2017 02; 197(2S):S216-S223. PMID: 28012773.
      View in: PubMed
    30. Brucker BM, Campeau L, Fong E, Kalra S, Rosenblum N, Nitti VW. Radiation Exposure During Videourodynamics: Establishing Risk Factors. Low Urin Tract Symptoms. 2018 May; 10(2):181-185. PMID: 27990783.
      View in: PubMed
    31. Drain A, Khan A, Ohmann EL, Brucker BM, Smilen S, Rosenblum N, Nitti VW. Use of Concomitant Stress Incontinence Surgery at Time of Pelvic Organ Prolapse Surgery Since Release of the 2011 Notification on Serious Complications Associated with Transvaginal Mesh. J Urol. 2017 04; 197(4):1092-1098. PMID: 27866958.
      View in: PubMed
    32. Malacarne DR, Nitti VW. Post-Sling Urinary Retention in Women. Curr Urol Rep. 2016 Nov; 17(11):83. PMID: 27678391.
      View in: PubMed
    33. Brucker BM, Nitti VW, Kalra S, Herbert J, Sadiq A, Utomo P, Aponte MM. Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms. Neurourol Urodyn. 2017 Apr; 36(4):1208-1213. PMID: 27548624.
      View in: PubMed
    34. Rac G, Younger A, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, MacLachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner ES. Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications. Neurourol Urodyn. 2017 04; 36(4):1155-1160. PMID: 27460448.
      View in: PubMed
    35. Rovner E, Kohan A, Chartier-Kastler E, Jünemann KP, Del Popolo G, Herschorn S, Joshi M, Magyar A, Nitti V. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol. 2016 Sep; 196(3):801-8. PMID: 27091236.
      View in: PubMed
    36. Drain A, Nitti VW. Clinical Case Discussion: Failure of a Midurethral Sling Procedure for Stress Urinary Incontinence in a Female Patient. Eur Urol Focus. 2016 Aug; 2(3):335-336. PMID: 28723384.
      View in: PubMed
    37. Hoffman DS, Nitti VW. Female Bladder Outlet Obstruction. Curr Urol Rep. 2016 Apr; 17(4):31. PMID: 26902625.
      View in: PubMed
    38. Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep; 196(3):791-800. PMID: 27038769.
      View in: PubMed
    39. Wagg A, Nitti VW, Kelleher C, Castro-Diaz D, Siddiqui E, Berner T. Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics. Curr Med Res Opin. 2016; 32(4):621-38. PMID: 26828974.
      View in: PubMed
    40. Younger A, Rac G, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, Maclachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner E. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications. Urology. 2016 05; 91:46-51. PMID: 26845051.
      View in: PubMed
    41. Chartier-Kastler E, Nitti V, De Ridder D, Sussman D, Sand P, Sievert K, Chapple C, Charmaine J, Magyar A, Radomski S. Durable improvements in urinary incontinence and positive treatment response in patients with idiopathic overactive bladder syndrome following long-term onabotulinumtoxinA treatment: Final results of 3.5-year study. Prog Urol. 2015 Nov; 25(13):739. PMID: 26544243.
      View in: PubMed
    42. Rosa GM, Ferrero S, Nitti VW, Wagg A, Saleem T, Chapple CR. Cardiovascular Safety of ß3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome. Eur Urol. 2016 Feb; 69(2):311-23. PMID: 26422675.
      View in: PubMed
    43. Chapple CR, Osman NI, Birder L, van Koeveringe GA, Oelke M, Nitti VW, Drake MJ, Yamaguchi O, Abrams P, Smith PP. The underactive bladder: a new clinical concept? Eur Urol. 2015 Sep; 68(3):351-3. PMID: 25770481.
      View in: PubMed
    44. Mitchell SA, Brucker BM, Kaefer D, Aponte M, Rosenblum N, Kelly C, Hickling D, Nitti VW. Evaluating patients' symptoms of overactive bladder by questionnaire: the role of urgency in urinary frequency. Urology. 2014 Nov; 84(5):1039-43. PMID: 25443897.
      View in: PubMed
    45. Chapple C, Khullar V, Nitti VW, Frankel J, Herschorn S, Kaper M, Blauwet MB, Siddiqui E. Efficacy of the ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. Eur Urol. 2015 Jan; 67(1):11-14. PMID: 25092537.
      View in: PubMed
    46. Brucker BM, Nitti VW. Urodynamics. Urol Clin North Am. 2014 Aug; 41(3):xiii. PMID: 25063604.
      View in: PubMed
    47. Cruz F, Nitti V. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB). Neurourol Urodyn. 2014 Jul; 33 Suppl 3:S26-31. PMID: 25042140.
      View in: PubMed
    48. Comiter CV, Rhee EY, Tu LM, Herschorn S, Nitti VW. The virtue sling--a new quadratic sling for postprostatectomy incontinence--results of a multinational clinical trial. Urology. 2014 Aug; 84(2):433-8. PMID: 24972946.
      View in: PubMed
    49. Cardozo L, Staskin D, Currie B, Wiklund I, Globe D, Signori M, Dmochowski R, MacDiarmid S, Nitti VW, Noblett K. Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Int Urogynecol J. 2014 Dec; 25(12):1655-63. PMID: 24859795.
      View in: PubMed
    50. Sievert KD, Chapple C, Herschorn S, Joshi M, Zhou J, Nardo C, Nitti VW. OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder. Int J Clin Pract. 2014 Oct; 68(10):1246-56. PMID: 24754838.
      View in: PubMed
    51. Nitti VW, Chapple CR, Walters C, Blauwet MB, Herschorn S, Milsom I, Auerbach S, Radziszewski P. Safety and tolerability of the ß3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial. Int J Clin Pract. 2014 Aug; 68(8):972-85. PMID: 24703195.
      View in: PubMed
    52. Nitti VW, Mourtzinos A, Brucker BM. Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study. J Urol. 2014 Sep; 192(3):836-42. PMID: 24650425.
      View in: PubMed
    53. Wagg A, Cardozo L, Nitti VW, Castro-Diaz D, Auerbach S, Blauwet MB, Siddiqui E. The efficacy and tolerability of the ß3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients. Age Ageing. 2014 Sep; 43(5):666-75. PMID: 24610862.
      View in: PubMed
    54. Chapple CR, Nitti VW, Khullar V, Wyndaele JJ, Herschorn S, van Kerrebroeck P, Blauwet MB, Siddiqui E. Onset of action of the ß3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World J Urol. 2014 Dec; 32(6):1565-72. PMID: 24458878.
      View in: PubMed
    55. Gomes CM, Sammour ZM, Bessa Junior Jd, Barbosa ER, Lopes RI, Sallem FS, Trigo-Rocha FE, Bruschini H, Nitti VW, Srougi M. Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease. Clinics (Sao Paulo). 2014; 69(12):817-22. PMID: 25627993.
      View in: PubMed
    56. Brucker BM, Demirtas A, Fong E, Kelly C, Nitti VW. Artificial urinary sphincter revision: the role of ultrasound. Urology. 2013 Dec; 82(6):1424-8. PMID: 24295256.
      View in: PubMed
    57. Brucker BM, Nitti VW. Reply: To PMID 24295256. Urology. 2013 Dec; 82(6):1429. PMID: 24295258.
      View in: PubMed
    58. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014 Feb; 65(2):389-98. PMID: 24184024.
      View in: PubMed
    59. Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn. 2014 Jan; 33(1):17-30. PMID: 24127366.
      View in: PubMed
    60. Lee T, Rosenblum N, Nitti V, Brucker BM. Uterine sparing robotic-assisted laparoscopic sacrohysteropexy for pelvic organ prolapse: safety and feasibility. J Endourol. 2013 Sep; 27(9):1131-6. PMID: 23713544.
      View in: PubMed
    61. Angulo JC, Khullar V, Nitti VW, Siddiqui E. Evidence available on the use of the selective ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder. Actas Urol Esp. 2013 Nov-Dec; 37(10):640-51. PMID: 23850394.
      View in: PubMed
    62. Bates D, Burks J, Globe D, Signori M, Hudgens S, Denys P, Macdiarmid S, Nitti V, Odderson I, Ross AP, Chancellor M. Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurol. 2013 Jul 09; 13:78. PMID: 23837535.
      View in: PubMed
    63. Nitti VW, Rosenberg S, Mitcheson DH, He W, Fakhoury A, Martin NE. Urodynamics and safety of the ß3-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction. J Urol. 2013 Oct; 190(4):1320-7. PMID: 23727415.
      View in: PubMed
    64. Nitti VW, Khullar V, van Kerrebroeck P, Herschorn S, Cambronero J, Angulo JC, Blauwet MB, Dorrepaal C, Siddiqui E, Martin NE. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract. 2013 Jul; 67(7):619-32. PMID: 23692526.
      View in: PubMed
    65. Aponte MM, Shah SR, Hickling D, Brucker BM, Rosenblum N, Nitti VW. Urodynamics for clinically suspected obstruction after anti-incontinence surgery in women. J Urol. 2013 Aug; 190(2):598-602. PMID: 23567748.
      View in: PubMed
    66. Andersson KE, Martin N, Nitti V. Selective ß3-adrenoceptor agonists for the treatment of overactive bladder. J Urol. 2013 Oct; 190(4):1173-80. PMID: 23458471.
      View in: PubMed
    67. Mischinger J, Amend B, Reisenauer C, Bedke J, Naumann G, Germann M, Kruck S, Arenas Desilva LF, Wallwiener H, Koelbl H, Nitti V, Sievert KD. Different surgical approaches for stress urinary incontinence in women. Minerva Ginecol. 2013 Feb; 65(1):21-8. PMID: 23412017.
      View in: PubMed
    68. Burks J, Chancellor M, Bates D, Denys P, Macdiarmid S, Nitti V, Globe D, Signori M, Hudgens S, Odderson I, Panicker J, Ross AP. Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients. Int J MS Care. 2013; 15(4):182-92. PMID: 24453782.
      View in: PubMed
    69. Hickling DR, Nitti VW. Management of recurrent urinary tract infections in healthy adult women. Rev Urol. 2013; 15(2):41-8. PMID: 24082842.
      View in: PubMed
    70. Brucker BM, Shah S, Mitchell S, Fong E, Nitti MD, Kelly CE, Rosenblum N, Nitti VW. Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction. Female Pelvic Med Reconstr Surg. 2013 Jan-Feb; 19(1):46-50. PMID: 23321659.
      View in: PubMed
    71. Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun; 189(6):2186-93. PMID: 23246476.
      View in: PubMed
    72. Winters JC, Dmochowski RR, Goldman HB, Herndon CD, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012 Dec; 188(6 Suppl):2464-72. PMID: 23098783.
      View in: PubMed
    73. Nitti VW, Auerbach S, Martin N, Calhoun A, Lee M, Herschorn S. Results of a randomized phase III trial of mirabegron in patients with overactive bladder. J Urol. 2013 Apr; 189(4):1388-95. PMID: 23079373.
      View in: PubMed
    74. Nitti VW. Complications of midurethral slings and their management. Can Urol Assoc J. 2012 Oct; 6(5 Suppl 2):S120-2. PMID: 23092771.
      View in: PubMed
    75. Nitti VW. Appropriate workup for lower urinary tract symptoms in men. Can Urol Assoc J. 2012 Oct; 6(5 Suppl 2):S141-2. PMID: 23092780.
      View in: PubMed
    76. Hickling D, Aponte M, Nitti V. Evaluation and management of outlet obstruction in women without anatomical abnormalities on physical exam or cystoscopy. Curr Urol Rep. 2012 Oct; 13(5):356-62. PMID: 22872500.
      View in: PubMed
    77. Brucker BM, Fong E, Kaefer D, Shah S, Rosenblum N, Nitti VW. Urodynamic findings in women with insensible incontinence. Int J Urol. 2013 Apr; 20(4):429-33. PMID: 22970923.
      View in: PubMed
    78. Lee E, Nitti VW, Brucker BM. Midurethral slings for all stress incontinence: a urology perspective. Urol Clin North Am. 2012 Aug; 39(3):299-310. PMID: 22877712.
      View in: PubMed
    79. Brucker BM, Fong E, Shah S, Kelly C, Rosenblum N, Nitti VW. Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women. Urology. 2012 Jul; 80(1):55-60. PMID: 22748864.
      View in: PubMed
    80. Nitti VW. Long-term continence after surgery--what can we tell patients? J Urol. 2012 Apr; 187(4):1157-8. PMID: 22335877.
      View in: PubMed
    81. Løvvik A, Yaqub S, Oustad H, Sand TE, Nitti VW. Can noninvasive evaluation of benign prostatic obstruction be optimized? Curr Opin Urol. 2012 Jan; 22(1):1-6. PMID: 22080874.
      View in: PubMed
    82. Comiter CV, Nitti V, Elliot C, Rhee E. A new quadratic sling for male stress incontinence: retrograde leak point pressure as a measure of urethral resistance. J Urol. 2012 Feb; 187(2):563-8. PMID: 22177174.
      View in: PubMed
    83. Nitti V. Clinical testing for overactive bladder. Can Urol Assoc J. 2011 Oct; 5(5 Suppl 2):S137-8. PMID: 21989526.
      View in: PubMed
    84. Han JS, Brucker BM, Demirtas A, Fong E, Nitti VW. Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding. J Urol. 2011 Oct; 186(4):1370-5. PMID: 21855941.
      View in: PubMed
    85. Shah SR, Biggs GY, Rosenblum N, Nitti VW. Surgical management of Skene's gland abscess/infection: a contemporary series. Int Urogynecol J. 2012 Feb; 23(2):159-64. PMID: 21732101.
      View in: PubMed
    86. Bauer RM, Gozzi C, Hübner W, Nitti VW, Novara G, Peterson A, Sandhu JS, Stief CG. Contemporary management of postprostatectomy incontinence. Eur Urol. 2011 Jun; 59(6):985-96. PMID: 21458914.
      View in: PubMed
    87. Nitti VW. Editorial comment. Urology. 2011 Feb; 77(2):479; author reply 480. PMID: 21295255.
      View in: PubMed
    88. Rosenblum N, Nitti VW. Female urethral reconstruction. Urol Clin North Am. 2011 Feb; 38(1):55-64, vi. PMID: 21353080.
      View in: PubMed
    89. Nitti VW. Editorial comment. Urology. 2011 Feb; 77(2):325; author reply 325. PMID: 21295250.
      View in: PubMed
    90. Dmochowski R, Chapple C, Nitti VW, Chancellor M, Everaert K, Thompson C, Daniell G, Zhou J, Haag-Molkenteller C. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010 Dec; 184(6):2416-22. PMID: 20952013.
      View in: PubMed
    91. Fong E, Nitti VW. Urinary incontinence. Prim Care. 2010 Sep; 37(3):599-612, ix. PMID: 20705201.
      View in: PubMed
    92. Fong ED, Nitti VW. Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int. 2010 Sep; 106(5):596-608. PMID: 21050350.
      View in: PubMed
    93. Staskin D, Michel MC, Nitti V, Morrow JD, Wang J, Guan Z. Efficacy of fesoterodine over 24 hours in subjects with overactive bladder. Curr Med Res Opin. 2010 Apr; 26(4):813-8. PMID: 20121659.
      View in: PubMed
    94. Nitti VW, Kopp Z, Lin AT, Moore KH, Oefelein M, Mills IW. Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion. Neurourol Urodyn. 2010 Apr; 29(4):652-7. PMID: 20432330.
      View in: PubMed
    95. Ballert KN, Rose AE, Biggs GY, Rosenblum N, Nitti VW. Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures? J Urol. 2010 Apr; 183(4):1455-8. PMID: 20171698.
      View in: PubMed
    96. Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, Dubeau C, Fry C, Hanno P, Smith JH, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek D, Wein A, Wyndaele JJ. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010; 29(1):213-40. PMID: 20025020.
      View in: PubMed
    97. Ballert KN, Nitti VW. Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling. J Urol. 2010 Feb; 183(2):641-5. PMID: 20018325.
      View in: PubMed
    98. Nitti VW, Rovner ES, Bavendam T. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75. PMID: 19889062.
      View in: PubMed
    99. Mufarrij PW, Ballert KN, Nitti VW. Fistulization between ectopic ureteral stump and uterus following nephroureterectomy: case report. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Dec; 20(12):1505-7. PMID: 19444370.
      View in: PubMed
    100. Sand PK, Morrow JD, Bavendam T, Creanga DL, Nitti VW. Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul; 20(7):827-35. PMID: 19495545.
      View in: PubMed
    101. Kumar A, Litt ER, Ballert KN, Nitti VW. Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose? J Urol. 2009 Mar; 181(3):1231-5. PMID: 19152937.
      View in: PubMed
    102. Shah S, Nitti VW. Defining efficacy in the treatment of overactive bladder syndrome. Rev Urol. 2009; 11(4):196-202. PMID: 20111632.
      View in: PubMed
    103. Biggs GY, Ballert KN, Rosenblum N, Nitti V. Patient-reported outcomes for tension-free vaginal tape-obturator in women treated with a previous anti-incontinence procedure. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Mar; 20(3):331-5. PMID: 19107314.
      View in: PubMed
    104. Ballert KN, Biggs GY, Isenalumhe A, Rosenblum N, Nitti VW. Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach. J Urol. 2009 Feb; 181(2):679-84. PMID: 19091337.
      View in: PubMed
    105. MacDiarmid SA, Peters KM, Chen A, Armstrong RB, Orman C, Aquilina JW, Nitti VW. Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc. 2008 Sep; 83(9):1002-10. PMID: 18775200.
      View in: PubMed
    106. Colman S, Chapple C, Nitti V, Haag-Molkenteller C, Hastedt C, Massow U. Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder. Urology. 2008 Oct; 72(4):803-7. PMID: 18722655.
      View in: PubMed
    107. Rovner ES, Rackley R, Nitti VW, Wang JT, Guan Z. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93. PMID: 18639327.
      View in: PubMed
    108. Khullar V, Rovner ES, Dmochowski R, Nitti V, Wang J, Guan Z. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43. PMID: 18342923.
      View in: PubMed
    109. Nitti VW. Urodynamics, Incontinence, and Neurourology: Highlights from the Society for Urodynamics and Female Urology Annual Winter Meeting, February 28-March 2, 2008, Miami, FL. Rev Urol. 2008; 10(3):229-31. PMID: 18836560.
      View in: PubMed
    110. Nitti VW, Dmochowski R, Sand PK, Forst HT, Haag-Molkenteller C, Massow U, Wang J, Brodsky M, Bavendam T. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 2007 Dec; 178(6):2488-94. PMID: 17937959.
      View in: PubMed
    111. Ballert KN, Kanofsky JA, Nitti VW. Effect of tension-free vaginal tape and TVT-obturator on lower urinary tract symptoms other than stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Mar; 19(3):335-40. PMID: 17874026.
      View in: PubMed
    112. Padmanabhan P, Nitti VW. Primary bladder neck obstruction in men, women, and children. Curr Urol Rep. 2007 Sep; 8(5):379-84. PMID: 17880837.
      View in: PubMed
    113. Mayer RD, Dmochowski RR, Appell RA, Sand PK, Klimberg IW, Jacoby K, Graham CW, Snyder JA, Nitti VW, Winters JC. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007 May; 69(5):876-80. PMID: 17482925.
      View in: PubMed
    114. Fischer MC, Huckabay C, Nitti VW. The male perineal sling: assessment and prediction of outcome. J Urol. 2007 Apr; 177(4):1414-8. PMID: 17382743.
      View in: PubMed
    115. Twiss CO, Fischer MC, Nitti VW. Comparison between reduction in 24-hour pad weight, International Consultation on Incontinence-Short Form (ICIQ-SF) score, International Prostate Symptom Score (IPSS), and Post-Operative Patient Global Impression of Improvement (PGI-I) score in patient evaluation after male perineal sling. Neurourol Urodyn. 2007; 26(1):8-13. PMID: 17016797.
      View in: PubMed
    116. Akikwala TV, Fleischman N, Nitti VW. Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol. 2006 Nov; 176(5):2093-7. PMID: 17070266.
      View in: PubMed
    117. Kanofsky JA, Nitti VW. Tolterodine for treatment of overactive bladder. Urol Clin North Am. 2006 Nov; 33(4):447-53, viii. PMID: 17011380.
      View in: PubMed
    118. Padmanabhan P, Nitti VW. Female stress urinary incontinence: how do patient and physician perspectives correlate in assessment of outcomes? Curr Opin Urol. 2006 Jul; 16(4):212-8. PMID: 16770116.
      View in: PubMed
    119. Nitti VW, Dmochowski R, Appell RA, Wang JT, Bavendam T, Guan Z. Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia. BJU Int. 2006 Jun; 97(6):1262-6. PMID: 16686723.
      View in: PubMed
    120. Denys P, Corcos J, Everaert K, Chartier-Kastler E, Fowler C, Kalsi V, Nitti V, Schulte-Baukloh H, Schurch B. Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies. Curr Med Res Opin. 2006 May; 22(5):851-60. PMID: 16709307.
      View in: PubMed
    121. Nitti VW, Sanders S, Staskin DR, Dmochowski RR, Sand PK, MacDiarmid S, Maibach HI. Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology. 2006 Apr; 67(4):657-64. PMID: 16618554.
      View in: PubMed
    122. Denys P, Corcos J, Everaert K, Chartier-Kastler E, Fowler C, Kalsi V, Nitti V, Schulte-Baukloh H, Schurch B. Improving the global management of the neurogenic bladder patient: part I. The complexity of patients. Curr Med Res Opin. 2006 Feb; 22(2):359-65. PMID: 16466608.
      View in: PubMed
    123. Nitti VW. Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol. 2006; 8(4):198-208. PMID: 17192799.
      View in: PubMed
    124. Dmochowski RR, Nitti V, Staskin D, Luber K, Appell R, Davila GW. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J Urol. 2005 Sep; 23(4):263-70. PMID: 16151816.
      View in: PubMed
    125. Dmochowski RR, Sanders SW, Appell RA, Nitti VW, Davila GW. Bladder-health diaries: an assessment of 3-day vs 7-day entries. BJU Int. 2005 Nov; 96(7):1049-54. PMID: 16225527.
      View in: PubMed
    126. Nitti VW. Surgical treatment of stress urinary incontinence in women: is "clinical effectiveness" a valid concept? Curr Urol Rep. 2005 Sep; 6(5):319-21. PMID: 16120230.
      View in: PubMed
    127. Huckabay C, Nitti VW. Diagnosis and treatment of primary bladder neck obstruction in men. Curr Urol Rep. 2005 Jul; 6(4):271-5. PMID: 15978226.
      View in: PubMed
    128. Nitti V, Taneja S. Overactive bladder: achieving a differential diagnosis from other lower urinary tract conditions. Int J Clin Pract. 2005 Jul; 59(7):825-30. PMID: 15963211.
      View in: PubMed
    129. Scarpero HM, Padmanabhan P, Xue X, Nitti VW. Patient perception of videourodynamic testing: a questionnaire based study. J Urol. 2005 Feb; 173(2):555-9. PMID: 15643252.
      View in: PubMed
    130. Huckabay C, Twiss C, Berger A, Nitti VW. A urodynamics protocol to optimally assess men with post-prostatectomy incontinence. Neurourol Urodyn. 2005; 24(7):622-6. PMID: 16208638.
      View in: PubMed
    131. Nitti VW. Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia? Rev Urol. 2005; 7 Suppl 4:S49-55. PMID: 16986055.
      View in: PubMed
    132. Twiss C, Fleischmann N, Nitti VW. Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence. Neurourol Urodyn. 2005; 24(3):207-10. PMID: 15791628.
      View in: PubMed
    133. Nitti VW. Primary bladder neck obstruction in men and women. Rev Urol. 2005; 7 Suppl 8:S12-7. PMID: 16985885.
      View in: PubMed
    134. Nitti VW. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005; 7 Suppl 6:S14-21. PMID: 16986024.
      View in: PubMed
    135. Fleischmann NB, Nitti VW. Pelvic floor reconstruction: state-of-the-art and beyond. Urol Clin North Am. 2004 Nov; 31(4):757-67. PMID: 15474603.
      View in: PubMed
    136. Rosenblum N, Scarpero HM, Nitti VW. Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Nov-Dec; 15(6):373-7; discussion 377. PMID: 15278258.
      View in: PubMed
    137. Nitti VW. Duloxetine: a new pharmacologic therapy for stress urinary incontinence. Rev Urol. 2004; 6 Suppl 3:S48-55. PMID: 16985864.
      View in: PubMed
    138. Fiske J, Scarpero HM, Xue X, Nitti VW. Degree of bother caused by nocturia in women. Neurourol Urodyn. 2004; 23(2):130-3. PMID: 14983424.
      View in: PubMed
    139. Xiao CG, Du MX, Dai C, Li B, Nitti VW, de Groat WC. An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol. 2003 Oct; 170(4 Pt 1):1237-41. PMID: 14501733.
      View in: PubMed
    140. Gomelsky A, Nitti VW, Dmochowski RR. Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology. 2003 Sep; 62(3):391-9. PMID: 12946730.
      View in: PubMed
    141. Hartanto VH, Nitti VW. Recent advances in management of female lower urinary tract trauma. Curr Opin Urol. 2003 Jul; 13(4):279-84. PMID: 12811291.
      View in: PubMed
    142. Hartanto VH, Lightner DJ, Nitti VW. Endoscopic evacuation of Durasphere. Urology. 2003 Jul; 62(1):135-7. PMID: 12837442.
      View in: PubMed
    143. Stember DS, Scarpero HM, Nitti VW. Vaginal granulation tissue secondary to bone anchors: experience in two patients. J Urol. 2003 Jun; 169(6):2300-1. PMID: 12771779.
      View in: PubMed
    144. Scarpero HM, Fiske J, Xue X, Nitti VW. American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology. 2003 Jun; 61(6):1118-22. PMID: 12809877.
      View in: PubMed
    145. Scarpero HM, Dmochowski RR, Nitti VW. Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol. 2003 Mar; 169(3):1013-6. PMID: 12576834.
      View in: PubMed
    146. Nitti VW. Transdermal therapy for overactive bladder: present and future. Rev Urol. 2003; 5 Suppl 8:S31-6. PMID: 16985988.
      View in: PubMed
    147. Scarpero HM, Nitti VW. Management of urinary retention and obstruction following surgery for stress urinary incontinence. Curr Urol Rep. 2002 Oct; 3(5):354-9. PMID: 12354342.
      View in: PubMed
    148. Nitti VW, Lefkowitz G, Ficazzola M, Dixon CM. Lower urinary tract symptoms in young men: videourodynamic findings and correlation with noninvasive measures. J Urol. 2002 Jul; 168(1):135-8. PMID: 12050507.
      View in: PubMed
    149. Barnes NM, Dmochowski RR, Park R, Nitti VW. Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology. 2002 Jun; 59(6):856-60. PMID: 12031368.
      View in: PubMed
    150. Nitti VW, Carlson KV, Blaivas JG, Dmochowski RR. Early results of pubovaginal sling lysis by midline sling incision. Urology. 2002 Jan; 59(1):47-51; discussion 51-2. PMID: 11796279.
      View in: PubMed
    151. Nitti VW. Clinical impact of overactive bladder. Rev Urol. 2002; 4 Suppl 4:S2-6. PMID: 16986018.
      View in: PubMed
    152. Patel R, Nitti V. Bladder outlet obstruction in women: prevalence, recognition, and management. Curr Urol Rep. 2001 Oct; 2(5):379-87. PMID: 12084245.
      View in: PubMed
    153. Carlson KV, Nitti VW. Prevention and management of incontinence following radical prostatectomy. Urol Clin North Am. 2001 Aug; 28(3):595-612. PMID: 11590816.
      View in: PubMed
    154. Rosenblum N, Nitti VW. Post-urethral suspension obstruction. Curr Opin Urol. 2001 Jul; 11(4):411-6. PMID: 11429503.
      View in: PubMed
    155. Nitti VW. Improving conservative treatment of overactive bladder and urge incontinence--1 small step at a time. J Urol. 2001 Jul; 166(1):150-1. PMID: 11435844.
      View in: PubMed
    156. Govier FE, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001 Apr; 165(4):1193-8. PMID: 11257669.
      View in: PubMed
    157. Nitti VW. The prevalence of urinary incontinence. Rev Urol. 2001; 3 Suppl 1:S2-6. PMID: 16985992.
      View in: PubMed
    158. Carlson KV, Rome S, Nitti VW. Dysfunctional voiding in women. J Urol. 2001 Jan; 165(1):143-7; discussion 147-8. PMID: 11125384.
      View in: PubMed
    159. Carlson KV, Fiske J, Nitti VW. Value of routine evaluation of the voiding phase when performing urodynamic testing in women with lower urinary tract symptoms. J Urol. 2000 Nov; 164(5):1614-8. PMID: 11025717.
      View in: PubMed
    160. Kobashi KC, Dmochowski R, Mee SL, Mostwin J, Nitti VW, Zimmern PE, Leach GE. Erosion of woven polyester pubovaginal sling. J Urol. 1999 Dec; 162(6):2070-2. PMID: 10569572.
      View in: PubMed
    161. Nitti VW, Tu LM, Gitlin J. Diagnosing bladder outlet obstruction in women. J Urol. 1999 May; 161(5):1535-40. PMID: 10210391.
      View in: PubMed
    162. Nitti VW. Evaluation of the female with neurogenic voiding dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 1999; 10(2):119-29. PMID: 10384975.
      View in: PubMed
    163. Ficazzola MA, Nitti VW. The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings. J Urol. 1998 Oct; 160(4):1317-20. PMID: 9751344.
      View in: PubMed
    164. Nieder AM, Chun TY, Nitti VW. Total vaginal prolapse with multiple vesical calculi after hysterectomy. J Urol. 1998 Mar; 159(3):983. PMID: 9474200.
      View in: PubMed
    165. Kim YH, Horowitz M, Combs AJ, Nitti VW, Glassberg KI. The management of unilateral poorly functioning kidneys in patients with posterior urethral valves. J Urol. 1997 Sep; 158(3 Pt 2):1001-3. PMID: 9258129.
      View in: PubMed
    166. Kim YH, Horowitz M, Combs AJ, Nitti VW, Borer J, Glassberg KI. Management of posterior urethral valves on the basis of urodynamic findings. J Urol. 1997 Sep; 158(3 Pt 2):1011-6. PMID: 9258132.
      View in: PubMed
    167. Chernoff A, Horowitz M, Combs A, Libretti D, Nitti V, Glassberg KI. Periurethral collagen injection for the treatment of urinary incontinence in children. J Urol. 1997 Jun; 157(6):2303-5. PMID: 9146659.
      View in: PubMed
    168. Nitti VW, Kim Y, Combs AJ. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urol. 1997 Feb; 157(2):600-3. PMID: 8996367.
      View in: PubMed
    169. Kim YH, Horowitz M, Combs A, Nitti VW, Libretti D, Glassberg KI. Comparative urodynamic findings after primary valve ablation, vesicostomy or proximal diversion. J Urol. 1996 Aug; 156(2 Pt 2):673-6. PMID: 8683757.
      View in: PubMed
    170. Maccabee PJ, Lipitz ME, Desudchit T, Golub RW, Nitti VW, Bania JP, Willer JA, Cracco RQ, Cadwell J, Hotson GC, Eberle LP, Amassian VE. A new method using neuromagnetic stimulation to measure conduction time within the cauda equina. Electroencephalogr Clin Neurophysiol. 1996 Apr; 101(2):153-66. PMID: 8647020.
      View in: PubMed
    171. Nitti VW. The role of clinical research in the diagnosis and treatment of urinary incontinence. J Urol. 1996 Apr; 155(4):1268-9. PMID: 8632548.
      View in: PubMed
    172. Plawker MW, Fleisher JM, Nitti VW, Macchia RJ. Primary care practitioners: an analysis of their perceptions of voiding dysfunction and prostate cancer. J Urol. 1996 Feb; 155(2):601-4. PMID: 8558669.
      View in: PubMed
    173. Nitti VW, Adler H, Combs AJ. The role of urodynamics in the evaluation of voiding dysfunction in men after cerebrovascular accident. J Urol. 1996 Jan; 155(1):263-6. PMID: 7490851.
      View in: PubMed
    174. Nitti VW, Combs AJ. Correlation of Valsalva leak point pressure with subjective degree of stress urinary incontinence in women. J Urol. 1996 Jan; 155(1):281-5. PMID: 7490856.
      View in: PubMed
    175. Nitti VW, Lepor H. Urology. Controversies old and new. Lancet. 1995 Dec 23-30; 346 Suppl:s26. PMID: 9454044.
      View in: PubMed
    176. Borer JG, Nitti VW, Glassberg KI. Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism. J Urol. 1995 Apr; 153(4):1267-73. PMID: 7869527.
      View in: PubMed
    177. Combs AJ, Nitti VW. Significance of rectal contractions noted on multichannel urodynamics. Neurourol Urodyn. 1995; 14(1):73-80. PMID: 7742852.
      View in: PubMed
    178. Bali I, Abdu AF, Gloster ES, Nitti VW, Friedman EA. Penectomy in diabetic patients undergoing maintenance dialysis. Am J Nephrol. 1995; 15(2):152-6. PMID: 7733153.
      View in: PubMed
    179. Nitti VW, Raz S. Obstruction following anti-incontinence procedures: diagnosis and treatment with transvaginal urethrolysis. J Urol. 1994 Jul; 152(1):93-8. PMID: 8201698.
      View in: PubMed
    180. Nitti VW. Intravesical capsaicin for treatment of neurogenic bladder. Lancet. 1994 Jun 11; 343(8911):1448. PMID: 7911174.
      View in: PubMed
    181. Nitti VW, Kim Y, Combs AJ. Correlation of the AUA symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn. 1994; 13(5):521-7; discussion 527-9. PMID: 7530554.
      View in: PubMed
    182. Nitti VW. Ice-water test in urodynamic assessment. Lancet. 1993 Oct 30; 342(8879):1066-7. PMID: 8105305.
      View in: PubMed
    183. Raz S, Bregg KJ, Nitti VW, Sussman E. Transvaginal repair of vesicovaginal fistula using a peritoneal flap. J Urol. 1993 Jul; 150(1):56-9. PMID: 8510275.
      View in: PubMed
    184. Raz S, Nitti VW, Bregg KJ. Transvaginal repair of enterocele. J Urol. 1993 Apr; 149(4):724-30. PMID: 8455231.
      View in: PubMed
    185. Nitti VW, Bregg KJ, Sussman EM, Raz S. The Raz bladder neck suspension in patients 65 years old and older. J Urol. 1993 Apr; 149(4):802-7. PMID: 8455244.
      View in: PubMed
    186. Raz S, Sussman EM, Erickson DB, Bregg KJ, Nitti VW. The Raz bladder neck suspension: results in 206 patients. J Urol. 1992 Sep; 148(3):845-50. PMID: 1512837.
      View in: PubMed
    187. Nitti VW, Macchia RJ. Bladder cancer in geriatric patients. Alternatives to radical cystectomy. Clin Geriatr Med. 1990 Feb; 6(1):173-84. PMID: 2405977.
      View in: PubMed
    188. Nitti V. [Ceftizoxime and its place in the context of modern cephalosporins]. Clin Ter. 1986 May 15; 117(3):233-60. PMID: 3524975.
      View in: PubMed
    189. Virgilio R, Nitti V, Corsi G, Adorno V, Zofra S, Iepparelli G, Valentino B, Valentino D, Vigorito F. [Evaluation of multivariate statistical analysis in the use of markers for the differential diagnosis between bronchopneumopathies and lung tumors]. Recenti Prog Med. 1985 Dec; 76(12):629-34. PMID: 3832203.
      View in: PubMed
    190. Nitti V, Iuliano A. [Primary resistance of mycobacterium tuberculosis (studies related to the triennium 1973-6)]. Arch Monaldi. 1977 Jan-Apr; 32(1-2):29-39. PMID: 417694.
      View in: PubMed
    191. Nitti V, Virgilio R, Patricolo MR, Iuliano A. Pharmacokinetic study of intravenous rifampicin. Chemotherapy. 1977; 23(1):1-6. PMID: 832508.
      View in: PubMed
    192. Nitti V, de Michele G, Famiglietti B, Miniccuci E, Ortolani G, Sessa T, Lauro N. [Epidemiological survey of chronic bronchitis in the city of Napels with special reference to the role and possible interaction of various exogenous factors]. Bull Int Union Tuberc. 1976; 51(1 Pt 2):685-99. PMID: 1052916.
      View in: PubMed
    193. Nitti V, De Michele G. [Exogenous factors related to chronic bronchitis as determined by multi-center studies in the city of Naples. Presentation and interpretation of the results]. Arch Monaldi. 1975 Mar-Apr; 30(2):148-59. PMID: 1225233.
      View in: PubMed
    194. Nitti V, Delli Veneri F. [The place of intermittent treatment in the current framework of antitubercular chemotherapy]. Arch Monaldi. 1974 May-Aug; 29(3-4):314-25. PMID: 4463916.
      View in: PubMed
    195. Curci G, Claar E, Bergamini N, Ninni A, Claar GM, Ascione A, Nitti V. Studies on blood serum levels of rifampicin in patients with normal and impaired liver function. Chemotherapy. 1973 Oct; 19(4):197-205. PMID: 4772959.
      View in: PubMed
    196. Nitti V, Ninni A, Meola G, Iuliano A, Curci G. Comparative investigations of the enzyme-inducing activity of rifampicin and barbiturates in man. Chemotherapy. 1973 Oct; 19(4):206-10. PMID: 4772960.
      View in: PubMed
    197. Nitti V, Delli Veneri F, Ninni A, Marsico SA. [Intermittent therapy in tuberculosis]. Recenti Prog Med. 1973 Jul; 55(1):55-92. PMID: 4800779.
      View in: PubMed
    198. Nitti V. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects. Scand J Respir Dis Suppl. 1973; 84:180-5. PMID: 4593266.
      View in: PubMed
    199. Nitti V. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects]. Arch Monaldi. 1972 Jul-Aug; 27(4):454-74. PMID: 4217601.
      View in: PubMed
    200. Nitti V. Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971). Chest. 1972 Jun; 61(6):589-98. PMID: 4624281.
      View in: PubMed
    201. Curci G, Bergamini N, Delli Veneri F, Ninni A, Nitti V. Half-life of rifampicin after repeated administration of different doses in humans. Chemotherapy. 1972; 17(6):373-81. PMID: 5082603.
      View in: PubMed
    202. Nitti V, Delli Veneri F, Ninni A, Meola G. Rifampicin blood serum levels and half-life during prolonged administration in tuberculous patients. Chemotherapy. 1972; 17(2):121-9. PMID: 4558400.
      View in: PubMed
    203. Nitti V. [Problems and prospects of antitubercular drug therapy at the present time]. Rev Bras Med. 1971 Aug; 28(8):431-5. PMID: 5136037.
      View in: PubMed
    204. Nitti V. [Influence of immunity on the action of various tuberculostatic drugs]. Ftiziologia. 1971 May-Jun; 20(3):239-44. PMID: 5164059.
      View in: PubMed
    205. Nitti V. [On the role of the macroorganism in the appearance of bacillary resistance]. Ftiziologia. 1971 May-Jun; 20(3):245-8. PMID: 5005958.
      View in: PubMed
    206. Nitti V. [Trends in the general therapy of chronic aspecific bronchopneumopathies]. Arch Monaldi. 1971 May-Jan; 26(3):203-16. PMID: 5145194.
      View in: PubMed
    207. Nitti V, Catena E, Delli Veneri F, De Michele G, Marra A. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis. Am Rev Respir Dis. 1971 Mar; 103(3):329-37. PMID: 5005040.
      View in: PubMed
    208. Nitti V. Results and tolerance of prolonged rifampicin treatment in recent and chronic forms of pulmonary tuberculosis. Respiration. 1971; 28:Suppl:57-69. PMID: 4948629.
      View in: PubMed
    209. Curci G, Bergamini N, Delli Veneri F, Ninni A, Nitti V. [Kinetic rate constant changes of Rifampicin and bilirubin serum levels following single and repeated administration of different per kg doses in humans]. Arch Monaldi. 1970 Nov-Dec; 25(6):427-40. PMID: 5514802.
      View in: PubMed
    210. Nitti V, Delli Veneri F, Ninni A, Meola G. [Behavior of blood levels of rifampicin during the course of treatment]. Arch Monaldi. 1970 Jul-Aug; 25(4):310-20. PMID: 4949912.
      View in: PubMed
    211. Nitti V. Rifampicin in the treatment of pulmonary tuberculosis. Bull Int Union Tuberc. 1970 Jun; 43:57-9. PMID: 5425575.
      View in: PubMed
    212. Nitti V. [Problems and prospects of antitubercular chemotherapy at the present time]. Arch Monaldi. 1970 Mar-Apr; 25(2):115-26. PMID: 5510341.
      View in: PubMed
    213. Nitti V. Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs. Antibiot Chemother. 1970; 16:444-70. PMID: 5002308.
      View in: PubMed
    214. Nitti V, Ninni A, Marsico SA. [Intermittent treatment with Rifampicin in experimental tuberculosis in guinea pigs]. Arch Tisiol Mal Appar Respir. 1969 Dec; 24(12):923-43. PMID: 5312739.
      View in: PubMed
    215. Nitti V, Catena E, Ninni A, Marsico SA. [Activity of terizidone in experimental tuberculosis in rabbits]. Arch Tisiol Mal Appar Respir. 1969 Sep; 24(9):667-98. PMID: 5315045.
      View in: PubMed
    216. Nitti V. [Activity of rifampicin in the treatment of pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir. 1969 Jun; 24(6):453-93. PMID: 5315095.
      View in: PubMed
    217. Nitti V, Delli Veneri F, Marra A. [Rifomycin in treatment of chronic tuberculosis with bacilli resistant to standard medications]. Acta Tuberc Pneumol Belg. 1969; 60(3):455-65. PMID: 4906100.
      View in: PubMed
    218. Nitti V, Delli Veneri F, Centrella G. [Case report of a pleuro-pneumonic acute process of Pseudomonas aeruginosa, treated with gentamicin]. G Ital Chemioter. 1969 Jan-Sep; 16(1):199-201. PMID: 4998302.
      View in: PubMed
    219. Nitti V, Ninni A. In vivo bactericidal activity of rifampicin in combination with other antimycobacterial agents. Chemotherapy. 1969; 14(6):356-65. PMID: 4983709.
      View in: PubMed
    220. Nitti V, Ninni A, Iodice F. [The determination of mycobacterial resistance to Rifampicin with the proportion method. (Technical problems and definition of the critical levels)]. Arch Tisiol Mal Appar Respir. 1968 Dec; 23(12):979-1000. PMID: 4977268.
      View in: PubMed
    221. Nitti V. [Endogenous reinfection and exogenous reinfection in tubercular pathology]. Arch Tisiol Mal Appar Respir. 1968 Aug; 23(8):638-48. PMID: 4973804.
      View in: PubMed
    222. Nitti V. [Rifampicin in tuberculosis. Summary of the observations and discussion]. Arch Tisiol Mal Appar Respir. 1968 Jun; 23(6):487-96. PMID: 5309062.
      View in: PubMed
    223. Nitti V. [Rifamicin in the studies of the Scuola Tisiologica in Naples]. Arch Tisiol Mal Appar Respir. 1968 Apr; 23(4):271-92. PMID: 4981409.
      View in: PubMed
    224. Nitti V, Ninni A, Natali P. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid]. Arch Tisiol Mal Appar Respir. 1967 Oct; 22(10):859-70. PMID: 4975183.
      View in: PubMed
    225. Nitti V, Ninni A. [Activity of Rifampicin associated with other drugs on experimental tuberculosis in guinea pigs]. Arch Tisiol Mal Appar Respir. 1967 Oct; 22(10):871-95. PMID: 5304754.
      View in: PubMed
    226. Nitti V. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis]. Arch Tisiol Mal Appar Respir. 1967 Jun; 22(6):519-34. PMID: 4973216.
      View in: PubMed
    227. Nitti V, Catena E, Bariffi F, Delli Veneri F. [Therapeutic activity of the Rifampicin in pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir. 1967 May; 22(5):417-62. PMID: 5304770.
      View in: PubMed
    228. Nitti V. [The activity of Rifampicin in vitro on atypical mycobacteria]. Arch Tisiol Mal Appar Respir. 1967 May; 22(5):498-506. PMID: 4975206.
      View in: PubMed
    229. Nitti V, Catena E, Ninni A, Di Filippo A. Activity of rifampicin in experimental tuberculosis of the guinea pig. Chemotherapy. 1967; 12(6):369-400. PMID: 4968843.
      View in: PubMed
    230. Nitti V, Catena E, Ninni A, Di Filippo A. [Experimental studies of the antimycobacterial activity of Rifampicine]. Arch Tisiol Mal Appar Respir. 1966 Nov; 21(11):867-910. PMID: 4969274.
      View in: PubMed
    231. Nitti V, Ninni A, Centrella G. [The antimycobacterial activity of rifamycin B diethylamide]. Arch Tisiol Mal Appar Respir. 1966 May; 21(5):359-69. PMID: 5297199.
      View in: PubMed
    232. Nitti V. The antituberculous activity of rifamycin SV. Helv Med Acta. 1965 Dec; 32(6):603-24. PMID: 4958120.
      View in: PubMed
    233. Nitti V, Catena E, Tanzi PL, Ninni A. [Pulmonary tuberculosis in advanced age. Causes of death and anatomopathologic pictures]. Riv Anat Patol Oncol. 1965 Mar-Apr; 27(3):312-49. PMID: 5886063.
      View in: PubMed
    234. NITTI V, CATENA E, NINNI A. [ACTIVITY OF 4-4' DIISOAMYLOXYTHIOCARBANILIDE ON EXPERIMENTAL TUBERCULOSIS OF THE GUINEA PIG]. Arch Tisiol Mal Appar Respir. 1964 Nov; 19:859-88. PMID: 14339285.
      View in: PubMed
    235. NITTI V. [INFLUENCE OF THE STATE OF BACTERIAL AGGREGATION ON THE ACTIVITY OF RIFOMYCIN SV IN VITRO]. Arch Tisiol Mal Appar Respir. 1963 Jun; 18:594-600. PMID: 14072544.
      View in: PubMed
    236. NITTI V, NINNI A. [ANTI-MYCOBACTERIAL ACTIVITY OF RIFOMYCIN SV IN GUINEA PIGS]. Arch Tisiol Mal Appar Respir. 1963 Jun; 18:601-12. PMID: 14072545.
      View in: PubMed
    237. NITTI V. [ON THE ANTITUBERCULAR ACTIVITY OF ETHIONAMIDE]. G Ital Chemioter. 1963 Apr-Jun; 10:151-5. PMID: 14074253.
      View in: PubMed
    238. NITTI V. [Antimycobacterial activity of rifamycin SV in vitro]. Arch Tisiol Mal Appar Respir. 1963 Mar; 18:177-89. PMID: 13938848.
      View in: PubMed
    239. NITTI V, VIRGILIO R, NINNI A. [Modifications of the bacteriologic findings in tuberculotics subjected to treatment with rifamycin SV]. Arch Tisiol Mal Appar Respir. 1963 Mar; 18:269-80. PMID: 13938849.
      View in: PubMed
    240. NITTI V. [THE ROUTES AND METHODS OF ADMINISTRATION OF RIFAMYCIN SV. THE TOLERANCE OF THE BODY]. Chemotherapia (Basel). 1963; 12:482-91. PMID: 14185774.
      View in: PubMed
    241. NITTI V. [The determinism of allergy in tuberculosis. (Experimental data)]. Arch Tisiol Mal Appar Respir. 1962 Nov; 17:850-61. PMID: 13938847.
      View in: PubMed
    242. NITTI V, NINNI A. [The resistance of Mycobacterium tuberculosis to rifamycin SV]. Arch Tisiol Mal Appar Respir. 1962 May; 17:357-73. PMID: 14480073.
      View in: PubMed
    243. NITTI V, VIRGILIO R, NINNI A. [Activity of rifomycin SV on mycobacteria in vitro]. Arch Tisiol Mal Appar Respir. 1961 Dec; 16:1023-78. PMID: 14480074.
      View in: PubMed
    244. NITTI V, MIRAGLIA E, ANZANO O. [Contribution to the knowledge of biologically incapsulated post-pleuritic empyema]. Arch Tisiol Mal Appar Respir. 1961 Jun; 16:485-506. PMID: 13729296.
      View in: PubMed
    245. NITTI V. [Considerations on current epidemiological and clinical aspects and on therapeutic problems of tuberculosis when first detected]. Lotta Tuberc. 1961 May; 31:433-6. PMID: 14480075.
      View in: PubMed
    246. MONALDI V, CURCI G, NITTI V. [Rifomycin SV: a new antibiotic against Mycobacterium tuberculosis. Prelimnary note]. Arch Tisiol Mal Appar Respir. 1961 May; 16:361-73. PMID: 13771953.
      View in: PubMed
    247. NITTI V, VIRGILIO R. [Morpho-structural aspects of Mycobacterium tuberculosis under the action of various anti-bacterial drugs]. Arch Tisiol Mal Appar Respir. 1961 Apr; 16:349-58. PMID: 13729299.
      View in: PubMed
    248. CURCI G, DE VITA C, NITTI V, PERRELLA F, ANZANO O, NINNI A. [On the audiotoxic activity of dihydrostreptomycin (audiometric and statistical observations)]. Arch Tisiol Mal Appar Respir. 1961 Feb; 16:141-59. PMID: 13882673.
      View in: PubMed
    249. NITTI V, VIRGILIO R. [Observations on the morphology of tubercular mycobacteria studied by the electron microscope]. Arch Tisiol Mal Appar Respir. 1960 Nov; 15:1076-85. PMID: 13729300.
      View in: PubMed
    250. NITTI V, MIRAGLIA E, VIRGILIO R. [Observations on the therapeutic activity of ethioniamide]. Arch Tisiol Mal Appar Respir. 1960 Oct; 15:971-95. PMID: 13729297.
      View in: PubMed
    251. NITTI V, CANTARELLA R. [Action of discontinuous contact with kanamycin on Mycobacterium tuberculosis in vitro]. Riv Ist Sieroter Ital. 1960 Sep-Oct; 35:556-63. PMID: 13729295.
      View in: PubMed
    252. NITTI V, VIRGILIO R. [Action of the thioamide of alpha-ethylisonicotinic acid on the morphology of Mycobacterium tuberculosis (research by electron microscopy)]. Riv Ist Sieroter Ital. 1960 Sep-Oct; 35:515-28. PMID: 13729298.
      View in: PubMed
    253. CURCI G, NITTI V. [Mechanism of action "in vivo" of isoniazid in the findings of the Naples school]. Arch Tisiol Mal Appar Respir. 1960 Aug; 15:797-808. PMID: 13718886.
      View in: PubMed
    254. D'ALFONSO G, NITTI V. [On the reentrance of former tuberculotics into the working life. (Observations on trends in the field)]. Arch Tisiol Mal Appar Respir. 1960 Mar; 15:255-9. PMID: 13719133.
      View in: PubMed
    255. NITTI V, VIRGILIO R. [The activity of kanamycin on the growth curve of Mycobacterium tuberculosis. Note 2. Action of kanamycin associated with other antibacterial agents]. G Clin Med. 1960 Mar; 41:326-44. PMID: 14427379.
      View in: PubMed
    256. NITTI V, VIRGILIO R. [The action of kanamycin on the growth curve of Mycobacterium tuberculosis. Note 1. Activity of kanamycin alone]. G Clin Med. 1960 Feb; 41:249-61. PMID: 14427378.
      View in: PubMed
    257. NITTI V, MIRAGLIA E. [On some pictures of malformative bronchopneumopathy due to anatomic defect. (Radiological and clinical study)]. Arch Tisiol Mal Appar Respir. 1959 Nov; 14:1077-106. PMID: 14427375.
      View in: PubMed
    258. NITTI V, MEOLA G. [In vitro bactericidal activity of alpha-ethyl-isonicotinic acid thioamide]. Riv Ist Sieroter Ital. 1959 Sep-Oct; 34:373-81. PMID: 14427374.
      View in: PubMed
    259. NITTI V, VIRGILIO R. [Recent acquisitions on bacterial cytology in the light of electron microscopy, with special reference to mycobacterial]. Arch Tisiol Mal Appar Respir. 1959 Sep; 14:239-56. PMID: 14427377.
      View in: PubMed
    260. NITTI V. [The thioamide of 2-ethylisonicotinic acid and its antimycobacterial activity in vitro]. Arch Tisiol Mal Appar Respir. 1959 Aug; 14:819-42. PMID: 14427380.
      View in: PubMed
    261. NITTI V, PARRELLA M, CANTARELLA R. [The bacterial chemoresistance at the time of admission]. Arch Tisiol Mal Appar Respir. 1959 Jul; 14:647-61. PMID: 14427376.
      View in: PubMed
    262. NITTI V. [Behavior of chemoresistant Mycobacterium tuberculosis in the chest of the living organism]. Gazz Med Ital. 1959 Apr; 118(4):131-4. PMID: 13664045.
      View in: PubMed
    263. NITTI V, VIRGILIO R. [Effects of kanamycin on the morphology of Mycobacterium tuberculosis; preliminary electron microscope data]. Arch Tisiol Mal Appar Respir. 1959 Jan; 14(1):3-29. PMID: 13650963.
      View in: PubMed
    264. NITTI V. [Bactericidal activity of kanamycin on Mycobacterium tuberculosis in vitro]. Arch Tisiol Mal Appar Respir. 1959 Jan; 14(1):37-49. PMID: 13650965.
      View in: PubMed
    265. NITTI V, CURCI G. [Mechanism of action of antitubercular chemotherapy according to the concepts of Phthisiological School of Naples]. Poumon Coeur. 1957 Jun; 13(6):526-38. PMID: 13453065.
      View in: PubMed
    266. NITTI V, TSUKAMURA M. [In vitro resistance of Mycobacterium tuberculosis to cycloserine]. Arch Tisiol Mal Appar Respir. 1957 Jan; 12(1):71-80. PMID: 13436225.
      View in: PubMed
    267. NITTI V, TANZI PL. [Bactericidal effect of cycloserine in vitro]. Arch Tisiol Mal Appar Respir. 1957 Jan; 12(1):42-9. PMID: 13436222.
      View in: PubMed
    268. MARRA A, NITTI V. [Therapeutic pneumothorax in physiomechanical equilibrium: bronchospirometric and ergometric aspects]. Arch Tisiol Mal Appar Respir. 1956 Aug; 11(8):602-10. PMID: 13382570.
      View in: PubMed
    269. NITTI V, CURCI G. [General aspects of chemoresistance of Mycobacterium tuberculosis and its relation to pathology and therapy]. Arch Tisiol Mal Appar Respir. 1955 Mar; 10(3):223-65. PMID: 14389070.
      View in: PubMed
    270. NITTI V, D'ALFONSO G. [Conditions and methods of appearance of reinfection in vaccination subjects]. Arch Tisiol Mal Appar Respir. 1955 Jan; 10(1):121-3. PMID: 14377870.
      View in: PubMed
    271. NITTI V, SCOZIA A. [Qualitative aspects and chronological order of tuberculous manifestations in vaccinated subjects; clinical and bibliographical study]. Arch Tisiol Mal Appar Respir. 1955 Jan; 10(1):9-21. PMID: 14377856.
      View in: PubMed
    272. NITTI V, CURCI G. [Chemoresistance of Mycobacterium tuberculosis; general aspects and relation to clinical manifestations and therapy; immunity and allergy in antibacterial-treated tuberculosis]. G Ital Chemioter. 1954 Jul-Dec; 1(3-4):390-421. PMID: 14391652.
      View in: PubMed
    273. NITTI V, DE ASCENTIS U. [The relation between resistance to isoniazid and resistance to other antibiotic compounds]. Arch Tisiol Mal Appar Respir. 1954 Feb; 9(2):98-105. PMID: 13159624.
      View in: PubMed
    274. NITTI V, CURCI G. [Isoniazid in the light of laboratory findings]. Arch Tisiol Mal Appar Respir. 1953 Nov; 8(11):859-916. PMID: 13139951.
      View in: PubMed
    275. NITTI V, CURCI G. [Laboratory investigations of isoniazid]. Minerva Med. 1953 Oct 20; 44(84):1132-3. PMID: 13119539.
      View in: PubMed
    276. NITTI V, CURCI G. [Isoniazid in the light of laboratory findings]. Lotta Tuberc. 1953 Oct-Nov; 23(10-11):848-52. PMID: 13153273.
      View in: PubMed
    277. PACINI D, NITTI V. [Aspects and situation of osteoarticular localization of miliary tuberculosis]. Arch Tisiol Mal Appar Respir. 1953 Jun; 8(6):448-75. PMID: 13105518.
      View in: PubMed
    278. NITTI V, TALIERCIO E. [Dubos' cytochemical reaction for the differentiation of virulent and avirulent mycobacteria; technical considerations and results]. Arch Tisiol Mal Appar Respir. 1953 May; 8(5):360-77. PMID: 13093310.
      View in: PubMed
    279. NITTI V, CURCI G. [Effect of culture filtrates on activity of isonicotinic acid hydrazide in vitro]. Arch Tisiol Mal Appar Respir. 1953 Mar; 8(3):201-5. PMID: 13058743.
      View in: PubMed
    280. NITTI V, TALIERCIO E. [Virulence of PAS resistant Mycobacterium tuberculosis]. Arch Tisiol Mal Appar Respir. 1952 Dec; 7(12):974-80. PMID: 13041536.
      View in: PubMed
    281. CURCI G, NITTI V. [So-called secondary therapeutic effects of isonicotinic acid hydrazide; experimental studies with isonicotinic acid hydrazide resistant bacteria]. Arch Tisiol Mal Appar Respir. 1952 Nov; 7(11):927-30. PMID: 13031868.
      View in: PubMed
    282. NITTI V. [Resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide]. Arch Tisiol Mal Appar Respir. 1952 Sep; 7(9):735-43. PMID: 13017972.
      View in: PubMed
    283. NITTI V, CANTARELLA R. [Role of anal fistula in tuberculosis]. Arch Tisiol Mal Appar Respir. 1952 Jul; 7(7):540-55. PMID: 13017954.
      View in: PubMed
    284. NITTI V. [Tuberculosis pathology in the vaccinated subject]. Arch Tisiol Mal Appar Respir. 1952 Jun; 7(6):453-9. PMID: 13017947.
      View in: PubMed
    285. NITTI V, DE MARCO F, LIGUORI R. [Pneumonectomy in pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir. 1952 May; 7(5):varia; 153-79. PMID: 13017930.
      View in: PubMed
    286. NITTI V, DE FRANCISCIS V. [Antagonism between PAS and PAB]. Arch Tisiol Mal Appar Respir. 1951 Dec; 6(12):1091-5. PMID: 14924891.
      View in: PubMed
    287. NITTI V. [Reversibility of the bacteriostatic action of PAS]. Boll Soc Ital Biol Sper. 1951 Dec; 27(12):1679-81. PMID: 14934919.
      View in: PubMed
    288. NITTI V. [In vitro effect of PAB on Mycobacterium tuberculosis and M. paratuberculosis]. Boll Soc Ital Biol Sper. 1951 Dec; 27(12):1681-8. PMID: 14934920.
      View in: PubMed
    289. NITTI V. [Lyophilization, general aspects and application to BCG vaccine]. Arch Tisiol Mal Appar Respir. 1951 Nov; 6(11):Varia, 429-41. PMID: 14915783.
      View in: PubMed
    290. NITTI V. [A new active antibiotic against Mycobacteria: viomycin]. Arch Tisiol Mal Appar Respir. 1951 Aug; 6(8):Varia, 299-304. PMID: 14878565.
      View in: PubMed
    291. MONALDI V, CURCI G, NITTI V. [Tuberculosis vaccination]. Rass Int Clin Ter. 1951 May 30; 31(10):320-1. PMID: 14864902.
      View in: PubMed
    292. NITTI V. [Tuberculous processes in subjects vaccinated with BCG]. Arch Tisiol Mal Appar Respir. 1951 Jan; 6(1):57-94. PMID: 14820591.
      View in: PubMed
    293. CURCI G, NITTI V. [Effect of TB1/698 on experimental tuberculosis of the guinea pig]. G Ital Della Tuberc. 1950 Nov-Dec; 4(6):442-4. PMID: 14813493.
      View in: PubMed
    294. NITTI V. [Resistance of Mycobacterium tuberculosis to p-aminosalicylic acid]. Arch Tisiol Mal Appar Respir. 1950 Sep; 5(9):765-7. PMID: 14791123.
      View in: PubMed
    295. NITTI V, MARRA A. [Effect of some vitamin factors on acquisition of streptomycin resistance by Mycobacterium tuberculosis]. Boll Soc Ital Biol Sper. 1950 Jul; 26(7):1066-8. PMID: 14811968.
      View in: PubMed
    296. NITTI V, DE FRANCISCIS V, CANTARELLA R. [Stability of PAS resistance in vitro and in vivo]. Boll Soc Ital Biol Sper. 1950 Jul; 26(7):1068-70. PMID: 14811969.
      View in: PubMed
    297. PACINI D, NITTI V. [Relation between pulmonary tuberculosis and osteoarticular tuberculosis. III. Osteoarticular processes in the course of pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir. 1950 Jul; 5(7):595-631. PMID: 14791104.
      View in: PubMed
    298. NITTI V. [Effect of PAS-resistant bacilli on activity of PAS in vitro]. Boll Soc Ital Biol Sper. 1950 Jul; 26(7):1063-5. PMID: 14811967.
      View in: PubMed
    299. NITTI V, DE FRANCISCIS V, CANTARELLA R. [Stability of PAS resistance in vitro and in vivo]. Arch Tisiol Mal Appar Respir. 1950 May; 5(5):444-52. PMID: 14777692.
      View in: PubMed
    300. NITTI V. [Streptomycin resistance of Mycobacterium tuberculosis, its bacteriological characteristics and clinical reactions: critico-synthetic review]. Arch Tisiol Mal Appar Respir. 1950 May; 5(5):Varia, 178-99. PMID: 14777688.
      View in: PubMed
    301. NITTI V. [Activity of PAS in the presence of pathological matter]. Arch Tisiol Mal Appar Respir. 1950 Apr; 5(4):350-5. PMID: 14777685.
      View in: PubMed
    302. NITTI V, DE FRANCISCIS V. [Reversibility of the bacteriostatic effect of streptomycin and PAS on Mycobacterium tuberculosis]. Boll Soc Ital Biol Sper. 1950 Apr; 26(4):523-4. PMID: 14791740.
      View in: PubMed
    303. NITTI V, CURCI G. [Hematic concentration and urinary elimination of PAS during continuous treatment]. Arch Tisiol Mal Appar Respir. 1950 Feb; 5(2):163-71. PMID: 15433831.
      View in: PubMed
    304. CURCI G, NITTI V. [The real and practical value of the inhibition of streptomycin by certain pathological substances]. Arch Tisiol Mal Appar Respir. 1950 Feb; 5(2):148-54. PMID: 15433829.
      View in: PubMed
    305. NITTI V, DE FRANCISCIS V, CANTARELLA R. [Streptomycin resistance in various clinical forms]. Arch Tisiol Mal Appar Respir. 1950 Jan; 5(1):69-74. PMID: 15420046.
      View in: PubMed
    306. NITTI V, DE FRANCISCIS V, CANTARELLA R. [Acquired PAS resistance in tubercle bacilli isolated during treatment]. Arch Tisiol Mal Appar Respir. 1950 Jan; 5(1):75-80. PMID: 15420047.
      View in: PubMed
    307. CURI G, NITTI V. [A new antitubercular drug, tuberculosis I of Domagk]. Prog Med (Napoli). 1949 Nov 15; 5(21):667. PMID: 15400851.
      View in: PubMed
    308. NITTI V, CURCI G. [Not Available]. Prog Med (Napoli). 1949 Mar 31; 5(6):186-90. PMID: 18120996.
      View in: PubMed
    309. GEMMI M, NITTI V. [Not Available]. Arch Tisiol Mal Appar Respir. 1948 Jan-Feb; 3(1):37-61. PMID: 18861592.
      View in: PubMed
    310. NITTI V, CURCI G, DE FRANCISCIS V. [Not Available]. Arch Tisiol Mal Appar Respir. 1947 Sep-Oct; 2(5):466-80. PMID: 18899859.
      View in: PubMed
    311. NITTI V. [Not Available]. Arch Tisiol Mal Appar Respir. 1947 Sep-Oct; 2(5):481-91. PMID: 18899860.
      View in: PubMed